IMMUNO-CYTOCHEMICAL STUDY OF THE APPEARANCE OF P-2 IN DEVELOPING RAT PERIPHERAL-NERVE - COMPARISON WITH OTHER MYELIN COMPONENTS

被引：39
|
作者：
WINTER, J [1 ]
MIRSKY, R [1 ]
KADLUBOWSKI, M [1 ]
机构：
[1] GUYS HOSP,SCH MED,DEPT MED,LONDON SE1 9RT,ENGLAND
来源：
JOURNAL OF NEUROCYTOLOGY | 1982年 / 11卷 / 03期
关键词：
D O I：
10.1007/BF01257982
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：351 / 362
页数：12
相关论文
共 45 条
  • [41] 1ST APPEARANCE OF LAMININ IN PERIPHERAL-NERVE, CEREBRAL BLOOD-VESSELS AND SKELETAL-MUSCLE OF THE RAT EMBRYO - IMMUNOFLUORESCENCE STUDY WITH LAMININ AND NEUROFILAMENT ANTISERA
    BIGNAMI, A
    CHI, NH
    DAHL, D
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1984, 2 (04) : 367 - 376
  • [42] Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
    Vogel, Victor G.
    Costantino, Joseph P.
    Wickerham, D. Lawrence
    Cronin, Walter M.
    Cecchini, Reena S.
    Atkins, James N.
    Bevers, Therese B.
    Fehrenbacher, Louis
    Pajon, Eduardo R., Jr.
    Wade, James L., III
    Robidoux, Andre
    Margolese, Richard G.
    James, Joan
    Lippman, Scott M.
    Runowicz, Carolyn D.
    Ganz, Patricia A.
    Reis, Steven E.
    McCaskill-Stevens, Worta
    Ford, Leslie G.
    Jordan, V. Craig
    Wolmark, Norman
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2727 - 2741
  • [43] BASIC-PROTEINS OF RODENT PERIPHERAL-NERVE MYELIN - IMMUNOCHEMICAL IDENTIFICATION OF THE 21.5K, 18.5K, 17K, 14K, AND P2 PROTEINS
    GREENFIELD, S
    WEISE, MJ
    GANTT, G
    HOGAN, EL
    BROSTOFF, SW
    JOURNAL OF NEUROCHEMISTRY, 1982, 39 (05) : 1278 - 1282
  • [44] Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial (vol 295, pg 2727, 2006)
    Vogel, V. G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (09): : 973 - 973
  • [45] Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial (vol 295, pg 2727, 2006)
    Vogel, V. G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24): : 2926 - 2926
12345